U.S. Healthtech Stock News

TJX Companies recently reported a strong past-quarter performance, with revenues rising 7.5% year on year, comparable-store sales up 5%, and management raising full-year guidance for sales, profit margin, and earnings per share. The company is pairing this momentum with an ambitious plan to expand its off-price store base to about 7,000 locations globally while returning US$3.10 billion to shareholders through buybacks and dividends in the first nine months of fiscal 2026. Now, we'll examine...

Origin Bancorp overview and recent performance Origin Bancorp (OBK) has attracted investor attention recently, with the share price around $40.44 and a mix of short term and longer term total returns that give a useful starting point for evaluating the stock. See our latest analysis for Origin Bancorp. While the latest 1-day share price return of 0.10% is relatively muted, the 90-day share price return of 19.40% and 1-year total shareholder return of 17.02% suggest momentum has been building...

Biohaven (BHVN) is back in focus after reporting early clinical experience from its MoDE and TRAP degrader platforms in IgA nephropathy and Graves' disease, along with a fresh pipeline update at a major healthcare conference. See our latest analysis for Biohaven. Biohaven's recent MoDE and TRAP degrader data, along with its high profile conference appearance, comes after a sharp rebound in momentum, with a 7 day share price return of 18.27% and a 30 day share price return of 21.11% from a...

Full Truck Alliance (YMM) came under pressure after JPMorgan cut its rating to Underweight, arguing that recent platform governance changes and international expansion have not yet translated into sustainable growth or margin improvement. See our latest analysis for Full Truck Alliance. The JPMorgan downgrade comes against a weaker backdrop for the stock, with a 30-day share price return showing an 11.17% decline and a 90-day return showing a 22.12% decline. The latest price of US$9.86 leaves...

Sila Realty Trust, Inc. recently completed the US$43.1 million acquisition of a fully leased inpatient rehabilitation facility in Oklahoma City, Oklahoma, which has been expanded to 58 beds and is operated under a long-term absolute-net lease with a corporate guaranty. This transaction reinforces Sila Realty Trust’s focus on healthcare real estate anchored by long-duration, necessity-based assets with strong occupancy and limited local competition, aiming to support consistent cash...

Erasca recently reported encouraging early Phase 1 AURORAS-1 data for its pan-RAS molecular glue degrader ERAS-0015, showing multiple partial responses across RAS-mutated tumor types with a clean safety profile and linear pharmacokinetics, while ERAS-4001 continued dose escalation in the BOREALIS-1 trial. What makes this update particularly interesting is that meaningful anti-tumor activity emerged at a relatively low 8 mg once-daily dose, potentially widening the drug’s future dosing window...

Why Vertiv Holdings Co (VRT) Is On Investors’ Radar Vertiv Holdings Co (VRT) has drawn attention after a recent move in its share price, with the stock last closing at $176.93, putting recent returns and fundamentals in focus for investors. See our latest analysis for Vertiv Holdings Co. Recent moves fit into a mixed picture, with a 1-day share price return of 2.54% and 7-day gain of 8.16%, alongside a modest 90-day share price return of 0.68%. At the same time, the 1-year total shareholder...

In recent days, coverage of Medical Properties Trust has focused on its upcoming earnings report, with analysts expecting quarterly EPS of $0.15 and revenue of about $245.22 million, both compared with the same period last year. An interesting angle is that, despite the forecast EPS decline, upward revisions to earnings estimates and a Zacks Rank of #2 (Buy) have pointed to improving analyst confidence in the REIT’s near-term outlook. Next, we’ll examine how these upward earnings revisions...

Texas Capital Bancshares (TCBI) has drawn investor attention after reporting record Q3 2025 earnings per share of $2.18, alongside 12% year-over-year revenue growth, and unveiling a new $200 million share repurchase program for 2026. See our latest analysis for Texas Capital Bancshares. Those record Q3 results and the new US$200m buyback come as the share price sits at US$98.01, close to its recent 52 week high. The 30 day share price return is 5.85%, the 90 day share price return is 20.14%,...

Limbach Holdings, Inc. recently appointed long-time leaders Nick Angerosa as Executive Vice President, National Customer Solutions, and Jay Sharp as Executive Vice President, Sales, and earlier in January added HVAC veteran Terry Dugan to its Board and Compensation Committee. Together, these leadership moves deepen Limbach’s building-systems expertise, reinforce its owner-direct and mission-critical focus, and may influence how the company pursues profitable growth, cash generation, and...

In January 2026, more than 100 Westchester and New York state officials urged regulators to reject Consolidated Edison’s 2026–2028 rate hike settlement, arguing even the reduced 2.8% electric and 2% gas increases would unduly burden residents and small businesses already struggling with affordability. The clash highlights how mounting concerns over customer arrears and cost-of-living pressures can intensify regulatory risk for a regulated utility heavily tied to New York City and surrounding...

Willis Lease Finance (WLFC) has just reshaped its growth playbook by pairing a planned US$1b aircraft engine leasing partnership with Blackstone Credit & Insurance with the launch of Willis Aviation Capital to manage third party aviation assets. See our latest analysis for Willis Lease Finance. The recent announcements appear to have caught the market’s attention, with a 1 month share price return of 36.98% and a 3 month share price return of 41.69% helping build short term momentum. This...

In January 2026, 10x Genomics and its partners, including Dana-Farber Cancer Institute, Brigham & Women’s Hospital, the Cancer Research Institute and CareDx, announced a series of collaborations to apply single-cell and spatial technologies across oncology, autoimmune disease, immuno-oncology and transplantation, alongside unaudited 2025 revenue of about US$642.8 million, or US$598.7 million excluding patent litigation settlements. These alliances, together with plans for a CLIA-certified...

Middleby: Recent Performance Snapshot Middleby (MIDD) has been trading quietly, with the share price last closing at US$148.53 and showing mixed returns, including a small move over the past month and a stronger gain across the past 3 months. See our latest analysis for Middleby. While Middleby’s 1-day share price return of 0.21% decline and 7-day share price return of 5.81% decline suggest some recent cooling, the 90-day share price return of 10.44% and 1-year total shareholder return of...

Several firms have recently downgraded Douglas Emmett (DEI), pointing to persistent weakness in occupancy and leasing momentum across its Los Angeles office portfolio, along with lower funds from operations estimates and a slower regional recovery. See our latest analysis for Douglas Emmett. The recent downgrades arrive after a difficult period for investors, with a 1 year total shareholder return of 32.94% decline and a 5 year total shareholder return of 50.07% decline. The latest US$11.12...

Ardent Health (ARDT) is back in focus after a series of securities class action lawsuits tied to disclosures on accounts receivable accounting, higher professional liability reserves, and alleged weaknesses in financial reporting controls. See our latest analysis for Ardent Health. At the latest share price of $8.60, Ardent Health has seen a 41.5% decline in its 90 day share price return and a 39.01% fall in 1 year total shareholder return. Recent lawsuits appear to be keeping pressure on...

Recent analyst calls on XPO (XPO), including fresh attention from Benchmark and Deutsche Bank, have put the freight carrier back in focus as investors weigh mixed sentiment, softer volumes, and upcoming leadership changes. See our latest analysis for XPO. At a share price of US$150.41, XPO has pulled back slightly in the last day after a strong 30 day share price return of 8.58% and a 90 day gain of 12.42%. Its 1 year total shareholder return of 9.33% sits alongside very large multi year...

Earlier this month, Penguin Solutions, Inc. reported first-quarter fiscal 2026 results showing revenue of US$343.07 million and net income of US$5.27 million, reaffirmed its full-year outlook with modestly adjusted earnings guidance, and highlighted past share repurchases totaling 3,101,884 shares for US$53.49 million. A key development was Penguin Solutions’ SMART Modular CXL NV-CMM E3.S 2T non-volatile memory module passing CXL 2.0 compliance testing and joining the CXL Consortium’s...

What recent performance suggests about Biglari Holdings (BH.A) Recent trading in Biglari Holdings (BH.A) has drawn attention, with the stock showing double digit returns over the past week, month, and past 3 months, prompting investors to reassess what is driving sentiment. See our latest analysis for Biglari Holdings. At a share price of $2,378.72, Biglari Holdings has seen a rapid shift in sentiment, with a 30 day share price return of 35.78% and a 1 year total shareholder return of...

Prudential Financial (PRU) is in focus after releasing preliminary fourth quarter 2025 figures and confirming the upcoming resignation of its Japan life unit CEO following staff misconduct issues. See our latest analysis for Prudential Financial. Recent events, including the preliminary fourth quarter 2025 update and governance concerns in Japan, come after a mixed year, with a 10.02% 90 day share price return but a 1 year total shareholder return of a 1.28% decline. This suggests short term...

Earlier this week, Brown-Forman expanded the national availability of its highly sought-after Woodford Reserve Double Double Oaked Bourbon, while also celebrating Old Forester’s heritage with a new documentary and the return of its 1924, 10-year-old age-stated Whiskey Row bourbon. These launches highlight how Brown-Forman is leaning on premium, story-rich bourbons to deepen brand loyalty at a time of industry headwinds. We’ll now examine how the nationwide Double Double Oaked release could...

Peabody Energy recently announced that its President and CEO, Jim Grech, has been appointed Chair of the National Coal Council, a federal advisory body that offers policy recommendations on coal to the U.S. Secretary of Energy. This appointment gives Peabody a higher-profile voice in coal policy discussions, which may influence how investors view the company’s role within the broader energy landscape. Next, we’ll examine how Grech’s new policy role could influence Peabody’s existing...

Southwest Airlines (LUV) is back in focus after analysts raised their earnings estimates and the stock picked up a Zacks Rank #2 (Buy), which signals a more constructive view on its earnings outlook. See our latest analysis for Southwest Airlines. The latest share price of US$43.12 comes after a 25.24% 90 day share price return and a 37.26% 1 year total shareholder return, suggesting momentum has picked up recently even though short term moves have been more mixed. If this shift in sentiment...

Alignment Healthcare (ALHC) is back in focus after reporting approximately 275,300 members on January 1, a 31% year-over-year increase, along with membership growth projections of 24% to 27% by the end of 2026. See our latest analysis for Alignment Healthcare. The strong membership update has arrived alongside a sharp shift in sentiment, with a 7 day share price return of 8.28% and a 90 day share price return of 29.38%, while the 1 year total shareholder return of 54.32% and 3 year total...